Rivus Pharmaceuticals Inc. announces executive appointments

Rivus Pharmaceuticals Inc. announced the appointment of Jayson Dallas as Chief Executive Officer, and the transition of Allen Cunningham to the role of Chief Operating Officer.

Jayson Dallas most recently served as the Executive Chairman for Rivus Pharmaceuticals. In this role, he will provide strategic leadership and guide the overall direction of the company.

Allen Cunningham previously held the post of Chief Executive Officer. In this role, he will be responsible for overseeing the day-to-day operations and clinical development of Rivus Pharmaceuticals’ lead candidate HU6.

Rivus Pharmaceuticals Inc. is a pharmaceutical company focused on developing innovative therapies for cardiometabolic diseases.